Healthcare

ImpediMed Limited (ASX:IPD) has announced the successful completion of its Share Purchase Plan (SPP), with shareholderDemandexceeding the original target amount. The company confirmed that the offer attracted applications worth AUD 3.5 million, prompting the Board to accept additional oversubscriptions and increase the total amount …

Micro-X Ltd (ASX:MX1) has achieved a significant development milestone in its Full Body CT program after completing the project's critical design review under its development agreement with the United States Government's Advanced Research Projects Agency for Health (ARPA-H). The completion of this stage enables …

Island Pharmaceuticals Ltd (ASX:ILA) shares gained 2.86% to AUD 0.36 during the morningTrading sessionon 10 June 2026 after the company announced an expansion of its existing CooperativeResearch and DevelopmentAgreement (CRADA) with the US Army Medical Research Institute of Infectious Diseases (USAMRIID) and The Geneva …

Ryman Healthcare Limited (ASX:RYM) (NZX:RYM) has launched a new fixed rate retail bond offer, seeking to raise up to NZ$100 million with the ability to accept up to a further NZ$50 million in oversubscriptions at the company’s discretion. The offer is for six-year fixed …

OncoSil Medical Ltd (ASX:OSL) operates in the interventional oncology segment, with a focus on targeted radiation-based treatment technologies for hard-to-treat cancers. The company’s flagship product, the OncoSil™ device, is designed for the localized delivery of phosphorus-32 microparticles directly into tumours.

Alterity Therapeutics Ltd (ASX:ATH) has reached a significant regulatory milestone after announcing successful alignment with the U.S. Food and Drug Administration (FDA) regarding the design of its pivotal Phase 3 clinical program for ATH434, the company's lead candidate for the treatment of Multiple System …

LTR Pharma Ltd (ASX:LTP) has taken a significant step in its international growth strategy following the execution of a binding commercial framework with Shed Holdings LLC, a U.S.-based direct-to-consumer telehealth platform. The agreement provides the first defined commercial pathway for ROXUS in the United …